Does NADOLOL Cause Nephrolithiasis? 7 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Nephrolithiasis have been filed in association with NADOLOL (Nadolol). This represents 0.4% of all adverse event reports for NADOLOL.
7
Reports of Nephrolithiasis with NADOLOL
0.4%
of all NADOLOL reports
0
Deaths
2
Hospitalizations
How Dangerous Is Nephrolithiasis From NADOLOL?
Of the 7 reports, 2 (28.6%) required hospitalization, and 1 (14.3%) were considered life-threatening.
Is Nephrolithiasis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NADOLOL. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does NADOLOL Cause?
Drug ineffective (989)
Macular degeneration (781)
Off label use (330)
Weight decreased (324)
Nausea (295)
Dyspepsia (263)
Abdominal pain (259)
Therapeutic product effect incomplete (251)
Pain (244)
Malaise (241)
What Other Drugs Cause Nephrolithiasis?
ADALIMUMAB (2,416)
ETANERCEPT (1,292)
INFLIXIMAB (981)
METHOTREXATE (979)
ABATACEPT (788)
TOPIRAMATE (768)
CERTOLIZUMAB PEGOL (735)
RITUXIMAB (709)
TOFACITINIB (699)
SODIUM OXYBATE (698)
Which NADOLOL Alternatives Have Lower Nephrolithiasis Risk?
NADOLOL vs NADROPARIN
NADOLOL vs NAFARELIN
NADOLOL vs NAFCILLIN
NADOLOL vs NAFCILLIN\NAFCILLIN
NADOLOL vs NAFRONYL